DVA
DaVita HealthCare Partners Inc
DaVita HealthCare Partners Inc historical holders
total: 9
Viking Global Investors DaVita HealthCare Partners Inc transactions over time
- Total transactions:
- 18
- New positions:
- 4
- Sold out:
- 4
- Added:
- 8
- Reduced:
- 2
- Held since:
- 2018 Q4
- Held for:
- 3 quarters
- Latest activity:
- 2019 Q3
Ole Andreas Halvorsen has been an institutional investor in DaVita HealthCare Partners Inc (DVA) since 2013 Q4. According to 2026 Q1 report, Ole Andreas Halvorsen doesn't hold any shares. The fund/company first acquired DVA in 2013 Q4, initially purchasing about 1.57M shares. Ole Andreas Halvorsen later completely sold out the position and reinvested in DVA again in 2018 Q4. Since the initial investment, Viking Global Investors has made 17 more transactions in this position.
When did Ole Andreas Halvorsen exit their DVA position?
Ole Andreas Halvorsen no longer holds DaVita HealthCare Partners Inc (DVA). They sold off their entire position in 2019 Q3, closing out an investment that began in 2013 Q4.
When did Ole Andreas Halvorsen first invest in DVA?
Ole Andreas Halvorsen first invested in DaVita HealthCare Partners Inc (DVA) in 2013 Q4 at the reported quarter-end price of $63.37 per share, acquiring 1,570,667 shares in their initial purchase.
What is Ole Andreas Halvorsen's average cost basis for DVA?
Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for DaVita HealthCare Partners Inc (DVA) is approximately $51.85 per share. This represents their average reported price* across all buy transactions.
Has Ole Andreas Halvorsen reinvested in DVA after selling?
Yes, Ole Andreas Halvorsen has shown renewed interest in DaVita HealthCare Partners Inc (DVA). After completely selling their position, they reinitiated an investment in 2018 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $51.85
- Weighted AVG sell price:
- $56.26
DVA transactions history by Viking Global Investors
18 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q3
|
0.00%
|
$56.26
|
-100% (-2,907,034)
|
|||
|
2019 Q2
|
0.73%
|
$56.26
|
+5.50% (+151,529)
|
|||
|
2019 Q1
|
0.86%
|
$54.29
|
+5.55% (+144,876)
|
|||
|
2018 Q4
|
0.76%
|
$51.46
|
new
|
|||
|
2017 Q2
|
0.00%
|
$67.97
|
-100% (-381,597)
|
|||
|
2017 Q1
|
0.11%
|
$67.97
|
new
|
|||
|
2016 Q3
|
0.00%
|
$77.32
|
-100% (-4,611,729)
|
|||
|
2016 Q2
|
1.51%
|
$77.32
|
+164.36% (+2,867,210)
|
|||
|
2016 Q1
|
0.56%
|
$73.38
|
new
|
|||
|
2015 Q4
|
0.00%
|
$72.33
|
-100% (-2,735,075)
|
|||
|
2015 Q3
|
0.76%
|
$72.33
|
-44.95% (-2,233,476)
|
|||
|
2015 Q2
|
1.49%
|
$79.47
|
-21.91% (-1,394,276)
|
|||
|
2015 Q1
|
2.00%
|
$81.28
|
+42.45% (+1,896,087)
|
|||
|
2014 Q4
|
1.55%
|
$75.74
|
+12.20% (+485,570)
|
|||
|
2014 Q3
|
1.17%
|
$73.14
|
+14.10% (+492,086)
|
|||
|
2014 Q2
|
1.10%
|
$72.32
|
+82.00% (+1,571,980)
|
|||
|
2014 Q1
|
0.55%
|
$68.85
|
+22.06% (+346,437)
|
|||
|
2013 Q4
|
0.46%
|
$63.37
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.